Display options
Cite
Bauer AZ, Swan SH, Kriebel D, et al. Reply to 'Paracetamol use in pregnancy - caution over causal inference from available data'; 'Handle with care - interpretation, synthesis and dissemination of data on paracetamol in pregnancy'. Nat Rev Endocrinol. 2021;doi: 10.1038/s41574-021-00610-1.
Bauer, A. Z., Swan, S. H., Kriebel, D., Liew, Z., Taylor, H. S., Bornehag, C. G., M Andrade, A., Olsen, J., Jensen, R. H., Mitchell, R. T., Skakkebaek, N. E., & Kristensen, D. M. (2021). Reply to 'Paracetamol use in pregnancy - caution over causal inference from available data'; 'Handle with care - interpretation, synthesis and dissemination of data on paracetamol in pregnancy'. Nature reviews. Endocrinology, . https://doi.org/10.1038/s41574-021-00610-1
Bauer, Ann Z, et al. "Reply to 'Paracetamol use in pregnancy - caution over causal inference from available data'; 'Handle with care - interpretation, synthesis and dissemination of data on paracetamol in pregnancy'." Nature reviews. Endocrinology vol. (2021). doi: https://doi.org/10.1038/s41574-021-00610-1
Bauer AZ, Swan SH, Kriebel D, Liew Z, Taylor HS, Bornehag CG, M Andrade A, Olsen J, Jensen RH, Mitchell RT, Skakkebaek NE, Kristensen DM. Reply to 'Paracetamol use in pregnancy - caution over causal inference from available data'; 'Handle with care - interpretation, synthesis and dissemination of data on paracetamol in pregnancy'. Nat Rev Endocrinol. 2021 Dec 14; doi: 10.1038/s41574-021-00610-1. Epub 2021 Dec 14. PMID: 34907342.
Copy Download .nbib Format: NLM
Share it on

Nat Rev Endocrinol. 2021 Dec 14; doi: 10.1038/s41574-021-00610-1. Epub 2021 Dec 14.

Reply to 'Paracetamol use in pregnancy - caution over causal inference from available data'; 'Handle with care - interpretation, synthesis and dissemination of data on paracetamol in pregnancy'.

Nature reviews. Endocrinology

Ann Z Bauer, Shanna H Swan, David Kriebel, Zeyan Liew, Hugh S Taylor, Carl-Gustaf Bornehag, Anderson M Andrade, Jørn Olsen, Rigmor H Jensen, Rod T Mitchell, Niels E Skakkebaek, David M Kristensen

Affiliations

  1. Department of Public Health, University of Massachusetts Lowell, Lowell, MA, USA.
  2. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  3. Yale Center for Perinatal, Pediatric, and Environmental Epidemiology, Yale School of Public Health, New Haven, CT, USA.
  4. Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, Yale-New Haven Hospital, New Haven, CT, USA.
  5. Department of Health Sciences, Karlstad University, Karlstad, Sweden.
  6. Departamento de Fisiologia, Setor de Ciências Biológicas, UFPR, Curitiba, Brazil.
  7. Department of Public Health, Aarhus University, Aarhus, Denmark.
  8. Department of Neurology, Danish Headache Center, Rigshospitalet-Glostrup, University of Copenhagen, Copenhagen, Denmark.
  9. MRC Centre for Reproductive Health, Queens Medical Research Institute, Edinburgh, Scotland.
  10. Department of Growth & Reproduction and EDMaRC, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  11. Department of Neurology, Danish Headache Center, Rigshospitalet-Glostrup, University of Copenhagen, Copenhagen, Denmark. [email protected].
  12. Univ Rennes, Inserm, EHESP, Irset, Rennes, France. [email protected].
  13. Department of Biology, University of Copenhagen, Copenhagen, Denmark. [email protected].

PMID: 34907342 DOI: 10.1038/s41574-021-00610-1

[No abstract available.]

References

  1. Bauer, A. Z. et al. Paracetamol use during pregnancy- a call for precautionary action. Nat. Rev. Endocrinol. 17, 757–766 (2021). - PubMed
  2. Alwan, S. et al. Paracetamol use in pregnancy — caution over causal inference from available data. Nat. Rev. Endocrinol. https://doi.org/10.1038/s41574-021-00606-x (2021). - PubMed
  3. Damkier, P. et al. Handle with care — interpretation, synthesis and dissemination of data on paracetamol in pregnancy. Nat. Rev. Endocrinol. https://doi.org/10.1038/s41574-021-00605-y (2021). - PubMed
  4. Bennett, D. et al. Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement. Environ. Health Perspect. 124, A118–A122 (2016). - PubMed
  5. Black, E. et al. Medication use and pain management in pregnancy: a critical review. Pain Pract. 19, 875–899 (2019). - PubMed
  6. Nordeng, H., Ystrøm, E. & Einarson, A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur. J. Clin. Pharmacol. 66, 207–214 (2010). - PubMed
  7. Sinclair, S. M., Miller, R. K., Chambers, C. & Cooper, E. M. Medication safety during pregnancy: improving evidence-based practice. J. Midwifery Womens Health 61, 52–67 (2016). - PubMed
  8. Kristensen, D. M. et al. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum. Reprod. 26, 235–244 (2011). - PubMed
  9. Van Calsteren, K. et al. Position statement from the European Board and College of Obstetrics & Gynaecology (EBCOG): The use of medicines during pregnancy - call for action. Eur. J. Obstet. Gynecol. Reprod. Biol. 201, 189–191 (2016). - PubMed
  10. Pharmacovigilance Risk Assessment Committee (PRAC). PRAC Recommendations on Signals https://www.ema.europa.eu/en/documents/prac-recommendation/prac-recommendations-signals-adopted-12-15-march-2019-prac-meeting_en.pdf (2019). - PubMed

Publication Types